1 day, 13 hours ago (2008-07-22 09:55:00)
by gfp927z
... were down 14% year- over-year, but things could get even worse as Vytorin missed its primary endpoint in the SEAS study (see below) and also showed a possible cancer link. MRK and SGP shares were hammered again (during regular trading and again in the AH session) and MRK has taken the unusual step of revoking all earnings guidance. Vytorin Hits Another Bump By PETER LOFTUS and ...
Source:
Investors Hub - Discussion Groups
Forum:
Cortex Pharmaceuticals (COR)
Thread: Show this thread (1 post) Size: 7,535 bytes Links: investorshub.com profile
Customize:
Forum:
Thread: Show this thread (1 post) Size: 7,535 bytes Links: investorshub.com profile
Customize:


